2022 American Transplant Congress Archives - Page 23 of 190

7:00pm-8:00pm: A Pilot Study Using Registry-Based External Controls for the Cyclosporine Arm of the BENEFIT Study

A. Klein¹, D. Stewart², A. Toll², W. E. Fitzsimmons¹

Kidney Immunosuppression: Novel Regimens and Drug Minimization • Hynes Halls C & D

7:00pm-8:00pm: A Prospective Randomised, Controlled Trial Switching Sirolimus For Mycophenolate To Enhance Immunological Responses To Third Dose Covid-19 Vaccination In Kidney Transplant Recipients With Poor Baseline Humoral Immunity

M. J. Tunbridge¹, G. Perkins², T. Salehi¹, B. Grubor-Bauk³, B. Sim¹, T. Ying⁴, J. J. Singer⁵, S. C. Barry⁶, P. Hissaria⁷, S. Chadban⁸, P. T. Coates¹

Kidney Immunosuppression: Novel Regimens and Drug Minimization • Hynes Halls C & D

7:00pm-8:00pm: A Qualitative Comparison of Declined Hispanic and Non-Hispanic Living Liver Donor Candidates at a High-Volume Urban Transplant Center

D. Toy¹, B. Horwich¹, A. Mulgaonkar¹, A. Padilla², J. L. Dodge³, N. Kaur⁴, H. Han³

Liver: Living Donor Liver Transplant and Partial Grafts • Hynes Halls C & D

7:00pm-8:00pm: A Safe and Feasible Method for Initiating Pure Laparoscopic Living Donor Right Hepatectomy; External Traction of the Cystic Duct

H. Choi¹, G. Na², H. Park¹, Y. Woo¹, Y. Choi¹, Y. You³

Liver: Living Donor Liver Transplant and Partial Grafts • Hynes Halls C & D

7:00pm-8:00pm: A Three-gene Peripheral Blood Potential Diagnosis Signature Associated With Autophagy For Antibody-mediated Rejection In Renal Transplantation

Y. Wang, Y. Xu, H. Zhang, X. Hu

Biomarkers: Clinical Outcomes • Hynes Halls C & D

7:00pm-8:00pm: Acute Tubular Injury and Necrosis Do Not Lead to Meaningful Elevations in Donor-Derived Cell-Free DNA (dd-cfDNA)

S. R. Allam¹, M. Cooper², D. Kumar³, T. Maw⁴, A. Wiseman⁵, P. Chuang⁶, G. Shekhtman⁷, N. Agrawal⁷, J. Zeng⁷, E. Huang⁸

Biomarkers: Clinical Outcomes • Hynes Halls C & D

7:00pm-8:00pm: Adherence, Outcomes and Adverse Effects in Pediatric Renal Transplant Patients After Early Steroid-Withdrawal and Low-Dose Calcineurin Inhibitor Maintenance Immunosuppression

A. Garcia¹, R. Plews¹, M. Moran¹, F. Trujillo¹, A. Martinez¹, N. Koizumi², D. Conti¹, J. Ortiz¹

Kidney Immunosuppression: Novel Regimens and Drug Minimization • Hynes Halls C & D

7:00pm-8:00pm: Adult-to-Adult Living Donor Liver Transplantation in Acute Liver Failure – Do Outcomes Justify the Risks?

A. Shingina¹, I. A. Ziogas², P. Vutien³, E. Uleryk⁴, E. Renner⁵, M. P. Bhat⁶, J. Tinmouth⁴, J. Kim⁷

Liver: Living Donor Liver Transplant and Partial Grafts • Hynes Halls C & D

7:00pm-8:00pm: Adverse Renal Events After BNT162b2 Pfizer/BioNTech COVID-19 Vaccine in Kidney Transplant Recipients

H. K. Sran¹, E. Wong¹, M. R. D'Costa², A. Lim², Q. Lim², A. Vathsala¹

All Infections (Excluding Kidney & Viral Hepatitis) IV • Hynes Halls C & D

7:00pm-8:00pm: Aftercare for Organ Donor Families: A Content Analysis of Organ Procurement Organization Family Services and Educational Materials

J. Akhtar¹, C. Sidoti¹, S. Klitenic¹, T. Storch², E. Hughes², C. Hagan³, A. Helman³, I. Johnson³, K. Vanterpool¹, H. Sung¹, L. Zeiser¹, M. Levan¹

Psychosocial and Treatment Adherence • Hynes Halls C & D